c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK)
about
VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancerVaccinia virus B1R kinase interacts with JIP1 and modulates c-Jun-dependent signalingMacro histone H2A1.2 (macroH2A1) protein suppresses mitotic kinase VRK1 during interphaseHuman VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleusPlk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentationProteomics identification of nuclear Ran GTPase as an inhibitor of human VRK1 and VRK2 (vaccinia-related kinase) activitiesp53 Stabilization and accumulation induced by human vaccinia-related kinase 1Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold proteinHuman VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expressionVRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damageVaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damageVRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damageVaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1p53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loopBiomarkers of head and neck cancer, tools or a gordian knot?Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy.PUMA: a unified framework for penalized multiple regression analysis of GWAS dataHuman VRK1 is an early response gene and its loss causes a block in cell cycle progression.Mice deficient in the serine/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogonia.Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage responseVaccinia-related kinase 1 is required for the maintenance of undifferentiated spermatogonia in mouse male germ cellsDownregulation of VRK1 by p53 in response to DNA damage is mediated by the autophagic pathway.Differential inhibitor sensitivity between human kinases VRK1 and VRK2.Functional disruption of the moloney murine leukemia virus preintegration complex by vaccinia-related kinases.Lack of neuroprotection of inhibitory peptides targeting Jun/JNK after transient focal cerebral ischemia in spontaneously hypertensive rats.Radiation-induced c-Jun activation depends on MEK1-ERK1/2 signaling pathway in microglial cells.Protein kinase Cδ regulates vaccinia-related kinase 1 in DNA damage-induced apoptosis.The changes of vaccinia related kinase 1 in grafted heart after rat heart transplantationVRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosisCaenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in post-mitotic nuclear envelope assemblyVRK1 regulates Cajal body dynamics and protects coilin from proteasomal degradation in cell cycleProtein kinase VRK-1 regulates cell invasion and EGL-17/FGF signaling in Caenorhabditis elegans.Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells.NHK-1 phosphorylates BAF to allow karyosome formation in the Drosophila oocyte nucleusMitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells.Mitogen-activated protein kinase phosphatase 2 regulates histone H3 phosphorylation via interaction with vaccinia-related kinase 1.Genetic and Targeted eQTL Mapping Reveals Strong Candidate Genes Modulating the Stress Response During Chicken Domestication.Interference with p53 functions in human viral infections, a target for novel antiviral strategies?Expression of vaccinia-related kinase 1 (VRK1) accelerates cell proliferation but overcomes cell adhesion mediated drug resistance (CAM-DR) in multiple myeloma.
P2860
Q24294283-81E0E874-AED3-4DAB-B8F3-76D2ACDB69AFQ24297063-95861870-6BC3-45F9-B3FB-4436E4396F8CQ24300500-864659A4-F309-4F57-8E7A-A62392ADCEA0Q24302043-C4C5DC1E-C262-4813-B75E-24535442A979Q24305440-14867906-1268-47B2-A1CD-78E5A7E58457Q24310419-6504C46C-FA18-404F-8E7B-4BB1537FDE24Q24312060-4DF0546F-1CDE-4115-B63C-245AFADE1D1BQ24314772-D3D78B64-3774-4BB6-838D-ABBF52518CDEQ24315684-EB02C078-0808-406C-B490-DF53BE6A75A1Q24321199-EEBAA9A0-2F9D-478A-A3E1-48E7207C9C63Q24329080-CD6F8475-A08F-4679-A06B-B02AF7954964Q24336079-F9311C83-AD23-4095-8E8A-FE42FC293618Q24337123-E33D2538-61BC-422B-8E47-23A1024842F9Q24337845-64D99A68-BA2E-4317-839D-F01B023444B2Q24548984-FA6CEFC2-6B6D-4D93-A2F1-8941F749CC15Q26784289-6F0998DD-E4FE-4F7C-ABA4-78E9D6558C66Q30441689-46FA1EAF-0BB7-4192-A657-65E84F9C1E8AQ30653367-40154BC5-E2A7-4DDE-82E6-C327B421E7C0Q33320538-AC1F36B3-CCF1-49CC-BF3B-B30D845DE6DBQ33573339-CEBFB1CD-C575-41AF-904F-93F1FA764EAFQ33688463-8C9AFB60-3FA8-4FC5-98E1-2ACE5E63C531Q33778479-EE1F18DA-AFD6-4F48-A7BB-48E6416BAB85Q33840938-B3FB7249-55CA-4420-B424-72B2F71010A9Q33988809-A8A8B535-C517-4850-9E67-F69E43CEE38FQ34025406-05C60C88-2776-4E3F-9CEF-F1AA093C53E8Q34039925-B8B3D969-5350-4480-BEAF-1F0BC629F0BCQ34273675-7156E82B-DA5F-4221-8F3B-D36A2916933DQ34803145-1ABF96D5-D6FE-432C-A364-7E217D2D7EADQ34814273-2468A814-87A9-4514-8C87-C4B5C9871C28Q35002396-78A76FBD-1C88-47A3-A2C9-84BF1B80FF7DQ35610597-506CC13E-0D78-44F0-A8B4-5B219A02EEE3Q35727732-CD542E54-C16D-4B7D-A7FE-A88FB373CA2AQ36042822-8E0F2D01-5490-47A1-AC5D-6E349A003C35Q36100030-45241BBC-0D9A-43FB-8CA7-5E51DEAD5610Q36176543-4116025A-9C97-4596-9FC8-BA31613C2E32Q36316439-5DD4A404-8131-4C5E-A2D6-D404DAA906EDQ36587956-E7EAF219-FFFD-44A1-B83B-E5F72BCCEBD1Q37629310-678974A6-82AF-48F3-BA9E-CCFD8D711CC6Q37897197-55B4DEFB-64C5-4A3D-B15E-F3A0FC72C14FQ38763444-7738CFB4-7702-40A2-83C5-3FD6A2ECFFAE
P2860
c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK)
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
c-Jun phosphorylation by the h ...... terminal kinase of c-Jun (JNK)
@ast
c-Jun phosphorylation by the h ...... terminal kinase of c-Jun (JNK)
@en
c-Jun phosphorylation by the h ...... terminal kinase of c-Jun (JNK)
@nl
type
label
c-Jun phosphorylation by the h ...... terminal kinase of c-Jun (JNK)
@ast
c-Jun phosphorylation by the h ...... terminal kinase of c-Jun (JNK)
@en
c-Jun phosphorylation by the h ...... terminal kinase of c-Jun (JNK)
@nl
prefLabel
c-Jun phosphorylation by the h ...... terminal kinase of c-Jun (JNK)
@ast
c-Jun phosphorylation by the h ...... terminal kinase of c-Jun (JNK)
@en
c-Jun phosphorylation by the h ...... terminal kinase of c-Jun (JNK)
@nl
P2860
P50
P3181
P356
P1433
P1476
c-Jun phosphorylation by the h ...... terminal kinase of c-Jun (JNK)
@en
P2093
Claudio R Santos
Ramiro Barcia
P2860
P2888
P304
P3181
P356
10.1038/SJ.ONC.1208015
P407
P577
2004-11-01T00:00:00Z
P5875
P6179
1031844439